Android Circuit: Samsung Raises Galaxy Prices, Oppo Pad Mini Teased, Microsoft Closing Outlook App

This week’s Android headlines: Galaxy Z Fold 7 price rises, Oppo’s Pad Mini and Find X9 Pro launch details, Honor 600’s image to video AI, OnePlus Pad 3 Pro tease, Outlook leaves Android and more…

Apple Loop: iPhone Fold Launch Dates, iPad Air Upgrade, iPhone 18 Pro Specs

This week’s Apple headlines: a larger iPhone 18 Pro, iPhone Fold launch date, Siri AI’s delay, iPad Air upgrade, MacBook Neo success, the return of Glider and more…

Unilever’s 300,000 Creators Signals a Founder-Led Consolidation

Unilever’s 300,000-creator network is the demand signal. An 81-deal M&A year is the supply signal. The creator economy’s consolidation cycle is here.

Crypto Stocks Rally As Bitcoin Breaks Two-Month High After Iran Reopens Strait

Crypto-exposed stocks are up around 30% this week as Middle East tensions ease.

35 Million Xfinity Customers Have Until August 14 To Claim $117.5 Million Settlement

Comcast agreed to a $117.5 million settlement after a 2023 breach exposed 35 million Xfinity customers. Eligible class members can claim up to $10,000 by Aug. 14.

OpenAI Wants Its AI To Help Scientists Make Discoveries Faster

Solving a century-old mystery about rubber. The space economy keeps booming. The physics of stir fry. All that and more in this week’s edition of The Prototype.

How Cobia Follow Southern Stingrays To Feast

Cobia, a fast-growing, offshore predator, have been spotted following southern stingrays in shallow Florida waters, feeding on prey stirred up by the rays.

Why Sam Altman’s Warning About A Big Cyberattack In 2026 Is Overblown

Sam Altman said in an interview he agrees that it’s possible there could be a “world shaking” cyberattack in 2026, but experts point to other more immediate risks.

Amazfit Cheetah 2 Pro Takes Aim At The Garmin Audience

The Amazfit Cheetah Pro is a feature-packed fitness watch for folks after a higher-end running wearable. Notable features include offline mapping and 32GB storage.

Genes Determine Response To GLP-1 Drugs

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from one‑size‑fits‑all treatment.